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Abstract 
Patients with acute lymphoblastic leukemia have a high five-year survival rate thanks to 
methotrexate (MTX). However, cognitive side effects are reported, characterized as chemo brain. 
The study investigated if impulsiveness is part of the aberrant cognitive functions after being 
exposed to MTX in the early stage of physical development. Adolescent rats were injected with 
either phosphate-buffered saline (PBS) or MTX. The novel object recognition (NOR) task was 
conducted a month after the injections to measure the memory deficits. The discounting task was 
performed after the rats completed training on a fixed-ratio one schedule for both levers. The 
NOR test showed both the PBS and MTX rats recognized the novel object; however, the PBS 
group spent more time inspecting the novel object than the MTX group. Initial results from two 
rats (one from each group) for the discounting task showed that the PBS-treated rat preferred the 
immediate reward at the beginning and had increased omissions during the later trials. The MTX 
rat showed a consistent preference for the immediate lever across the entire procedure. These 
composite findings suggested cognitive deficits are not apparent within one month of MTX 
treatment, yet the impulsiveness is more apparent after MTX exposure. 
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Adverse Aftereffects of Methotrexate as Chemotherapy on Cognitive Deficits in Rat Models  
Childhood Leukemia and Chemotherapy 
It has been known that childhood acute lymphoblastic leukemia (ALL) has a relatively 
good prognosis with over 80% of the patients having a five-year-after-cancer survival rate 
(Nathan et al., 2004; van der Plas et al., 2015). While the cure of the malignant cancer has been 
targeted as a priority in the past, psychiatrists have questioned the association of the cognitive 
dysfunction as an aftereffect of the chemotherapy in the pediatric brains (Ikonomidou, 2018). 
The main chemotherapy utilized for ALL patients is methotrexate (MTX). The effect of the 
chemotherapy can vary from one patient to another based on gender, age, and other 
demographics, yet the common adverse effects include disturbances in recalling memories, loss 
of ability to concentrate, and poor academic performance (van der Plas et al., 2015). These 
cognitive dysfunctions are commonly referred to as chemo brain or chemo fog since “fogginess” 
impairs the normal operation of the brain (Ikonomidou, 2018). Although there are many cases 
associated with the cognitive dysfunctions followed by traumatic brain injuries, including 
strokes, neurodegenerative diseases, and cerebral infarctions, the chemotherapy is a human 
intervention to treat an existing disease. Because the treatment is meant to minimize possible 
aberrant effects, it is important to consider ways to minimize any side effects resulting from the 
treatment. For instance, antiemetic drugs are given to treat the nausea associated with many 
chemotherapeutics (Dupuis, et al., 2016). 
The common age group affected by ALL ranges from two to five years old, which 
underlines the importance of protecting the quality of future life after overcoming this deadly 
disease. The young age of these patients demands further studies concerning the vulnerability of 
the developing brain to the toxicity of MTX. It also suggests that developing novel treatments to 
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prevent these impairments are of great importance for the medical community (Krull et al., 
2011). 
Methotrexate Mechanism of Action in Cancer 
MTX is the main chemotherapy for patients with ALL. MTX is often given orally, which 
is then directly digested by the stomach and undergoes metabolic processes (such as first-pass 
metabolism), reducing the degree of the toxicity of MTX to the body (Angelov et al., 2009). 
Intravenous (IV) administration of MTX is efficient in distributing the drug throughout the 
systemic circulation with the half-life of approximately 8-12 hours. Due to its lack in lipophilic 
property, the penetration of the drug across the vascular endothelium will occur slowly and 
require a high dose, which is around 1000mg/m2 (Bleyer, 1977). An alternative way to 
administer MTX is an injection through the subcutaneous tissue or by deep intramuscular 
injection, which will stimulate faster and higher intensity of the drug effects. To target brain 
tumors, scientists have developed a specific pathway to administer MTX, 
 which is to inject it intracerebroventricularly. This study suggests that the likelihood of 
MTX, naturally crossing the blood-brain barrier (BBB) is low as the tight endothelial junctions 
will prevent the larger molecules from being passed without specific transporters (Angelov et al., 
2009). However, IV administration of MTX with the high dose (>1000mg/m2) can reach the 
required concentration for the therapeutic effect on the brain tumor. This is because the plasma 
composed of three to ten percent cerebral spinal fluid (CSF), which allows the high dose of MTX 
to leak into the CSF (Comandone et al., 2005). 
MTX is a folic acid analogue, inhibiting the dihydrofolate reductase (DHFR) enzyme. 
This enzyme is involved in several essential pathways: to produce purines, pyrimidines, and 
interconversion of amino acids. DHFR enzyme catalyzes the reduction of dihydrofolic acid 
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(DHF) to tetrahydrofolic acid (THFA) that acts as the precursor of the formation of thymidine, 
purines, and methionine, ultimately leading to RNA and DNA synthesis (Breedveld et al., 2004). 
When MTX is introduced to those pathways, MTX plays a role as a competitive inhibitor of 
DHF because MTX and DHF are similar in their chemical structures. In addition, MTX has the 
affinity for DHFR about 1000-fold that of DHF, which then efficiently prevents the reaction 
progress. The lack of THFA due to the pathway inhibition by MTX blocks the DNA, RNA, and 
protein syntheses, consequently leading the affected cells to undergo apoptosis. This blockage of 
the pathway is especially fatal to the malignant tumor cells as they require significantly higher 
amount of DNA replications than the normal cells (Dheen, Kaur, & Ling, 2007). 
The further mechanism that is affected by a decreased amount of THFA is the lack of 
methionine protein availability in the cells, which is regulated by the conversion of THFA. 
Methionine protein is an essential component for RNA synthesis (specifically for transfer RNA), 
but more importantly playing its role in polyamines. Polyamines are found in high concentrations 
in tumor cells with the function of the proliferation of the cell divisions while decreasing the 
prospect of cellular apoptosis. To counteract the increased number of polyamines, the reduced 
amount of methionine will decrease the function of tRNA as methionine dictates the initiation of 
the polyamine synthesis. Disruption of producing a protein chain will ultimately destroy the fast-
growing cancer cells due to no working proteins in the cell (Hagner & Joerger, 2010).  
Epigenetics on MTX 
The use of MTX is also prominent in inflammatory autoimmune diseases such as 
rheumatoid arthritis (RA). DNA methylation is part of an epigenetic mechanism, which regulates 
and manages the expression of the gene. Clinical studies have discovered the significant increase 
in differential DNA methylation following the MTX treatment. An alteration of gene expression 
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allows the tendons around the affected joints to be repositioned, which then consequently 
strengthens the tendons around the patients’ joints. Although it is not completely mapped out, 
MTX’s wide range of influence in a biological system underlines the importance of investigating 
its complex mechanism in the body (Nair et al., 2019). 
Toxicity of MTX 
Damage in Microglial Cells 
Microglial cells are known to initiate and manage the inflammatory responses in the 
brain, playing essential roles in recognizing neuronal damage and phagocytizing dead particles. 
However, many studies have found the correlation between the neuronal loss in the consequence 
of the overactivated microglia in the brain. Physicians have found long-term neurological deficits 
in young patients who underwent chemotherapy (Dheen et al., 2007). The exact mechanism of 
microglial activation due to anti-metabolites, such as MTX is not well understood. A study 
suggests that MTX is accompanied by oxidative stressors in the brain, which restricts essential 
pathways taken in the cellular reactions (Rajamani, Muthuvel, Senthilvelan, & Sheeladevi, 
2006). Microglia are triggered in the brain, which gather cytokines and other immune responses 
to the affected area (Wen et al., 2018). This immunological signal accompanies neuronal 
damages introducing the synergetic effect of the apoptosis of the neurons (Seigers et al., 2010). 
Due to activated microglia’s detrimental effects, the future direction of the study can be targeting 
the inhibition of the microglial activation by administering a “rescue drug” that can compensate 
the toxicity of the MTX to the brain. 
Hindrance in Astrocytes and Oligodendrocytes 
Reactive oxygen species that cause oxidative stress in the cellular level further instigate 
the malfunction of astrocytes, whose roles are to connect the BBB and neural cells for the 
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purpose of delivering nutrients and communicating between the cells (Shao, Tan, Shi, & Zhou, 
2019). Oxidative stress induced by the chemotherapy in the brain not only provokes an apoptotic 
pathway in neurons but also disrupts the differentiation of oligodendrocytes (Mueller et al., 
2013). In the mouse models, the thickness of myelin sheaths showed significant reduction upon 
the MTX treatment compared to healthy controls. This phenomenon was persistent or became 
worse after six months of stopping the MTX treatment. Reported damage in white matter in the 
brain showed consistent results with the previous observation as incompletely differentiated 
oligodendrocytes will be hindered from synthesizing myelin sheaths (Kovalchuk & Kolb, 2017).  
Impulsivity and Brain Damage 
Failure to tolerate delays for better rewards indicates impulsiveness. This behavior can 
often be found in children, ranging approximately from three to five years old (Cardinal, 
Robbins, & Everitt, 2000). The most represented experiment to measure the delay-gratification 
for children in such ages was conducted at Stanford in 1972, called the Stanford marshmallow 
experiment by Walter Mischel. From the experiment, young children struggle not to eat a small 
marshmallow placed in front of them after they are told that they will be given two marshmallow 
pieces if they can wait for a few more minutes (Mischel, Ebbesen, & Zeiss, 1972). An ability to 
control one’s desire for better outcomes in the later time becomes more perfected as the brain 
develops throughout the growing phase from the youth to the period of adolescence and even to 
young adults. However, MTX disrupts the production of the normal level of the brain amines, 
including dopamine and serotonin (Madhyastha, Somayaji, Rao, Nalini, & Bairy, 2002, 2005). 
Insufficiency in such amine molecules in the developing brain can be detrimental, causing 
dysfunction of prefrontal cortex and basal ganglia, which are known to manage memory and 
behaviors (Langen et al., 2012; Whitaker-Azmitia, 2001; Zhang et al., 2010). 
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A similar trend happens with smokers. They tend to choose an immediate monetary 
reward rather than waiting a little longer to receive a greater value of rewards. This test is called 
the Kirby delay-discounting task (Jaroni, Wright, Lerman, & Epstein, 2004). The study shows 
that discounting the profit of delayed reward is prominent among smokers and drug abusers. 
They focus on the physical desire rather than to evaluate the aftermath of such decision, 
characterizing impulsive behavior. In addition, further analysis following the discounting task 
suggests that the impulsive conduct is correlated with worse performance in their academics and 
low attention abilities. This relationship indicates that testing impulsivity can predict the damage 
in releasing certain types of neurotransmitters that regulate rational thinking and intrinsic 
motivation. Such inputs are dopaminergic, serotonergic, noradrenergic, and cholinergic to 
execute proper prefrontal cognitive function. The low-quality performance can be treated and 
improved by targeting the neurotransmitters that are altered in relation to impulsive behavior as 
well as applying a behavior modification approach. This finding is essential for young survivors 
of ALL who exhibit similar phenotypic result in their cognitive abilities (Logue & Gould, 2014). 
Operant Conditioning and Delay Discounting Task 
Operant conditioning was first defined by B.F. Skinner in 1937 in a context of learning 
behavior by relating the environment and behavior. This method is indeed an efficient tool to 
investigate the behavioral changes based on either reinforcement or punishment with the intent 
of either inducing the targeted behavior or removing the targeted behavior. Two types of 
interventions (whether to add or eliminate) and two types of behavioral responses (whether to 
induce or prevent) can be combined and result in four possible experimental designs, including 
positive punishment, positive reinforcement, negative punishment, and negative reinforcement. 
Positive means adding an influential factor, while negative means taking away an influential 
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factor. Punishment is the concept to decrease the behavior, while the reinforcer is to increase the 
behavior. Then, positive punishment means adding something to decrease the behavior; positive 
reinforcement means adding something to increase the behavior; while negative punishment is to 
remove something to discourage the behavior; and negative reinforcement means to remove 
something to encourage the behavior. One important feature regarding operant conditioning is 
that the environmental conditions responsible for the behavior are known and that behavior can 
be very stable for long periods of time when conditions are not altered. Extinction of the 
behavior can occur under certain procedures despite no changes in the reinforcements to 
maintain behaviors such as with high-ratio schedules, yet some behaviors may be persistent in 
spite of reinforcement or punishment (Staddon & Cerutti, 2003). 
The delay-discounting method to assess impulsivity utilizes the positive reinforcement, 
where animal models can be reinforced by the number of sucrose pellets granted during the 
experimental session. Rats are encouraged to wait longer to receive more pellets and discounting 
occurs when a rat chooses the immediate lever instead of waiting longer for the larger reward. 
The behavior necessary for receiving either an immediate reward or a later reward can be the 
same, such as pressing the lever once. In this situation, only the delay serves as a factor. 
Additional factors  can be used, such as differential interval time rather than fixed interval time 
to determine the cutoff where the amount of delaying time compared to the reward (the number 
of sucrose pellets) is no longer effective (Thompson et al., 2017). 
Novel Object Recognition and Executive Function 
Novel object recognition (NOR) is to measure the recognition memory of experimental 
animal models who may have suffered from brain injury. Studies have shown that the rodents 
tend to spend more time with the novel object as they find it more interesting than the object with 
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which they are familiar. This study was first done by Ennaceur and Delacour (1988) and was 
continued to evaluate the behavioral and cognitive changes of the subjects (Grayson et al., 2015). 
This test will function as a positive control in the MTX-induced-rats study because the study 
aims to investigate the impulsive behavior, while the cognitive dysfunction is expected based on 
previous studies. 
Literature Gap and the Purpose 
The pathophysiology of the chemotherapy MTX on brain dysfunction is incompletely 
understood especially among the younger age group of patients. Cognitive deficits due to MTX 
are problematic especially for pediatric patients since the common age group affected by ALL is 
two to five. Recognizing phenotypic disorder (abnormal behavioral changes such as 
impulsiveness) induced by MTX will provide additional information on the MTX effect on the 
cognitive dysfunctions. Furthermore, observing MTX’s toxicity on an anatomical abnormality in 
the developing brain may inform the key region of the brain that can be protected. This study, 
therefore, asks whether the MTX-induced subjects show behavioral changes, including cognitive 
deficits and impulsivity by utilizing adolescent rat models to mimic the developing brain. 
Materials and Methods 
Animal Subjects 
Preliminary Study for Appropriate Sex Choice of the Rat Models. Adult male (n=12) 
and female (n=12) rats from Charles River were used for the preliminary study. Upon arrival, 
rats were group-housed by sex (two rats/cage) and were acclimated for one week with food and 
water ad libitum. The rats were grouped by their sex. Rats were singly housed during operant 
conditioning studies. 
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MTX Impact Study. Adolescent male (n=6) and female (n= 6) Sprague Dawley rats 
from Charles River were used for the MTX study. Upon arrival at postnatal day 20, the rats were 
singly housed  and acclimated for one week. The temperature was kept consistent (22°C 
minimum & 25°C maximum), and a controlled light cycle was applied to regulate the sleep cycle 
of the subjects. Then, the 6 rats were randomly selected (3 males and 3 females) as a control 
group (PBS, vehicle) and the rest as an MTX-induced group. The demographic data, including 
sex, weight and the physical appearance or abnormality were recorded. 
NOR Test Setting 
Novel object recognition (NOR) test was performed in a cardboard box (24-in x 18-in x 
18-in) with a Plexiglas bottom. The day before the actual NOR trial, the rats were allowed to 
explore the box for 5 minutes in order for them to be habituated to the experimental environment 
without objects in the box. The next day, all rats underwent a paired experiment—a sample trial 
took precedent over a test trial. The objects were 35 cm apart (Figure 1). Each trial was 
conducted for 3 minutes and the box was cleaned at the end of the experiment. For the sample 
trial, two identical objects were placed. There was a one-hour breaktime between the sample and 
the test trial. During the test trial, one object was the same as the previous test and the other 
object was a new object (novel object). All objects were fixed to the floor so that they could not 
be moved by the rats (Fardell, Vardy, Logge, & Johnston, 2010). 
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Figure 1. The NOR test trial box. The object in the left was the used as the familiar object, while 
the object in the right was used as the novel object (the box dimension: 24-in x 18-in x 18-in). 
 
Operant Conditioning Chambers  
Six identical chambers were used (Med Associates). Each apparatus was equipped with 
an overhead houselight (2.8-W). Two retractable levers with two stimulus lights above the levers 
were positioned opposite from the houselight, at a height easily reachable by the rats. Between 
the levers, a tray was located. Behind the tray, a tube was connected through which sucrose 
pellets were delivered from the pellet dispenser (Cardinal et al., 2002).  
Saline (PBS) and MTX Injection 
For MTX impact study, all rats were injected on postnatal day 26 into the intraperitoneal 
cavity. The amount of MTX was measured based on the rat weight (250mg of MTX in PBS (pH 
7.4) / kg of body weight). The solution was made one hour prior to the injection.  
Training  
Preliminary Study for Appropriate Sex Choice of the Rat Models. Rats were trained 
under a fixed-ratio 1 (FR1) schedule of reinforcement. In order to be included in subsequent 
experiments, rats had to achieve three days of responding for at least 50 pellets in a one-hour 
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time period. All 12 male rats and 11 female rats successfully completed this training within one 
month (3-4 weeks). 
MTX Impact Study. The animal subjects started training on postnatal day 30 because an 
adolescent period for the rats marks around 28-42 days (Hammerslag & Gulley, 2014). The rat 
models were put under a FR1 schedule of reinforcement. In order to be included in multiple 
subsequent experiments, the subjects had to first respond for 40 sucrose pellets with the left lever 
and then for 40 sucrose pellets on the right lever. In both cases, only one lever was available. The 
rats who completed the left lever training were moved to the right lever training. All chambers 
had the houselight on throughout the session and the session lasted for one hour, and rats were 
tested five times a week until the criterion was met. Four male rats (three control rats and one 
MTX-induced rat) and four female rats (three control rats and one MTX-induced rat) 
successfully completed this training within 3-4 weeks by reaching 40 pellets from the left lever 
and 40 pellets from the right lever.   
Experimental Sessions  
Preliminary Study for Appropriate Sex Choice of the Rat Models. Rats were run in 
the chamber for 30 minutes three times a week.  Rats were initially tested under an FR1 schedule 
that was increased to an FR2, 4, 8 and 16 each subsequent week. Rats were then tested in a 
variable-ratio 5 (VR5) schedule, fixed-interval 30 second (FI30) schedule, and variable-interval 
30 second (VI30) schedule over the next three weeks. 
MTX Impact Study. The experimental design for the choice procedure is based on the 
one developed by Evenden and Ryan (1966), which allows multiple modifications in days, time 
periods, and signaling methods. Rats were run in the chamber until completion of the procedure 
which can last from sixty to one-hundred minutes. The equal session took two times a week. 
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The overall experimental design is illustrated below (Figure 2). This schematic map is 
modified based on the previous study by Cardinal, Robbins, and Everitt. The session was 
initiated with the houselight switched off and the levers retracted. Each trial began with the 
houselight on and both levers extended. The rat was required to press either of the levers. If the 
rat missed the trial by not responding within 10 seconds at the start, it was recorded as a Type 1 
omission and the chamber was reset to the initial state in preparation for the next trial. The rats 
were offered two choices. The left lever was designed for the delayed, but greater rewards, five 
sucrose pellets (the time of delay increased as the trial continued for an hour), whereas the right 
lever was denoted for the immediate fulfillment of the request, but with less value, one sucrose 
pellet. The total number of sucrose pellets desired by the rats was counted. Also, rats’ choices 
between two levers as the delays became longer throughout the session were recorded to observe 
the threshold of when the value of instant one sucrose pellet was greater for the rats than the 
value of the long-waiting for the five sucrose pellets (Cardinal et al., 2002). 
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Figure 2. The schematic map each trial. The comparison between immediate and delayed 
responses are presented side by side in order to deliver two different pathways more clearly. The 
intertrial interval time is indicated as well as whether the houselight is switched on or off. The 
exact time of the delays is not represented since the delays will vary (increasing) throughout the 
session. 
 
Data Collection and Statistical Analysis   
Data were collected using the MED-PC® V Software Suite. Cumulative records were 
plotted usingSoftCR™ Pro. Graphs were produced using Microsoft® Office Excel 2016. Data 
were analyzed using IBM SPSS Statistics 24.   
AFTEREFFECTS OF METHOTREXATE ON COGNITIVE DEFICITS 17 
 
A general linear model was used to analyze behavioral data by testing an analysis of 
variance (ANOVA). Missing values due to omissions or absence of responses were excluded 
from analyses. Homogeneity of variance was tested and confirmed by Levene’s test. Mauchly’s 
test of sphericity was used to analyze repeated measures throughout the experiment. If the 
sphericity assumption was violated, the Huynh-Feldt epsilon was used to be corrected with more 
conservative values. The significant values were set to be α=0.05 throughout. The statistical 
difference of preference between immediate and delayed levers was compared between the 
control (PBS saline) and MTX-induced group, using a T-test. To observe the significant effect of 
MTX, ANOVA was used to measure the impact of saline and MTX on impulsivity across three 
session pairs. In the case of a significant result, a further test was done using Bonferroni. The 
correlation between the time from the MTX injection date and the incidence of omission was 
tested using linear regression. 
Results 
The study results were novel in that choice procedures were performed as a measure of 
impulsiveness targeting the impact of MTX in the animal models. Impulsiveness is the aberrant 
cognitive deficit additional to the executive function, measured by the NOR trials. In addition, 
studying adolescent rats, regarding the fact that they are in a critical stage of life in developing 
their brains, contributes to the future direction in determining the possible factors triggered by 
MTX on the impulsiveness of the rats. 
The Preliminary Study for the Choice of Sex of the Rat Models and Baseline 
In the preliminary experiment, the animal subjects were tested to demonstrate the intake 
of the number of sucrose pellets per rat to create the baseline. In addition, the sex difference of 
the animal models was evaluated to determine the best-fit animal models for the operant 
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conditioning. In the past, female rats were excluded from experimental studies primarily due to 
misconceptions about their ability to perform operant procedures, whether due to questions of 
stamina or cognition (Becker, Prendergast, & Liang, 2016). Sucrose pellets are often used as 
positive reinforcers; therefore, females might respond for half as many pellets because the body 
mass per height is twice as much as males. Exclusion of female rodents in preclinical studies 
may explain failures to generalize preclinical studies to clinical studies since half the US 
population is female. To analyze the natural tendency of the sucrose consumption based on sex, 
the rats were divided into male and female groups. The data suggest that the female rats, despite 
overall small body sizes compared to the male rats, showed an overall higher number of 
responses to sucrose than male rats (Figure 3).  
 
Figure 3. As a percent body weight, female rats respond more for sucrose pellets under a fixed-
ratio (FR) schedule of reinforcement in operant conditioning. (A) shows the number of 
reinforcers received, (B) shows responses, (C) shows variance between sexes for reinforcers 
received, and (D) shows amount of sucrose received as a percent body weight. A mixed two-way 
ANOVA was used for (A), (B) and (D) and Levene’s test for (C). (D) showed a significant 
interaction of sex and schedule (F4,84 = 5.64, p < 0.01). Variance among females was lower than 
males; however, this was only significant with an FR4 (F1,21 = 4.39, p =0.049). 
 
A B 
C D 
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Additional data indicate that female groups generally showed higher self-control 
compared to male groups with less frequent reinforcements (pressing the levers) due to delays. 
Enduring delays allowed the female rats to reach a higher number of sucrose pellets outcomes 
compared to the male rats (Figure 4). 
 
Figure 4. Responding by male and female rats under a variable-ratio 5 schedule. (A) shows 
average reinforcers received, (B) shows a box-and-whisker plot demonstrating the distribution of 
responses, (C) shows a representative cumulative record for a male rat, and (D) shows a 
representative cumulative record for a female rat. 
 
Based on the results illustrated from the graphs, the use of female rats provides as equally 
accurate operant conditioning response as the use of male rats. The baselines of sucrose 
consumption by males and females were established. The following study of the MTX-induced 
rat models, therefore, used both male and female rats. 
Sex Data and Abnormality of Stomach 
A bodyweight of the control group (saline-injected) increased throughout the experiment. 
The MTX-induced group had a period of weight decrease. However, the rats who tolerated the 
chemotherapy soon began to increase the bodyweight. The individual bodyweight measured 
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daily was averaged across each group (Figure 5). After the day 48, all rats showed consistent 
bodyweight increase regardless of saline or MTX injections. 
 
Figure 5. The weight change from age 20 day to 71 day. Injection of either PBS or MTX was 
performed on the rats on the day of 25. The decrease in body weight is evident on the day 26 and 
continues until the day 31. The MTX-induced rats began to show similar weight average as the 
saline-injected rats approximately on the day 48 after the birth. 
 
In the MTX-induced group, two male and two female rats did not tolerate the drug well and as a 
result, deceased throughout the span of 28 to 33 days. During this time, any abnormal behavior 
or physiological phenotype was noted. However, the rats who endured the MTX injection soon 
caught up the bodyweight of the control group. 
When the deceased rat models had undergone the dissection of the brain, their internal 
organs were also evaluated. Three out of four rats had an evidently enlarged stomach and did not 
have diarrhea, while the other rat suffered from diarrhea. These rats refused to consume sucrose 
pellets and did not show any bowel movements. The rat who had diarrhea and died showed 
normal size stomach. Such findings are consistent with studies that suggest constipation, 
abdominal pain, and esophageal disturbances are prominent among patients who ingest low-dose 
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MTX to treat rheumatoid arthritis (Tsukada, Nakano, Miyata, & Sasaki, 2013). The evidence of 
the enlarged stomachs from the MTX-injected rats underscores the toxicity of MTX on the 
intestinal lining. The rats who tolerated the MTX injection (n=2) started gaining weight again 
and were able to complete the training. 
Novel Object Recognition 
The time spent between the same objects during the sample trial was not significantly 
different as expected (p > 0.05). NOR test results showed that both saline-received and MTX-
induced rats showed similar cognitive function as they spent significantly longer on the novel 
object compared to the old object (p < 0.0001 and p = 0.0193, respectively). The amount of time 
spent for each object during the 3-min trial distinguished the preference of the novel object, 
indicating the intact working memory and proper cognitive functions (Figure 6). 
Figure 6. The preference between the familiar and the novel object based on the time the rats 
spend on each. A) The sample trial showed not much difference in their fondness on either left or 
right object in both groups, as expected (p > 0.05). B) The test trial, after replacing one familiar 
object with the novel object resulted in a significant difference in the preference of the object in 
both PBS and MTX (p < 0.0001 and p = 0.0193, respectively). Although the test trial showed the 
significance in both groups, the MTX-induced rats showed a little less significant result 
compared to the PBS-injected rats. 
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Both control and experimental groups seemed to recognize the novel object which displaced the 
old object they were familiar with. These results suggested that all rats demonstrated the minimal 
cognitive ability that is required to recall the familiar condition and the brand-new condition. 
Training and Sensitivity to Delay for Rewards 
All subjects learned to press the lever for food. A cumulative record for one rat is shown 
in Figure 7. However, only female rats completed the training course for both groups as the male 
rats did not reach the set-goal of the number of the sucrose pellets. 
 
Figure 7. The trend of rats pressing the lever throughout the course of training. After 3 days of 
training, the majority of the rats began to press levers. The number of lever presses is also 
consistent with the sucrose pellets provided. 
 
Based on the time it took for the rats to complete their training sessions, it was observed that the 
female rats overall achieved the goal of the number of sucrose pellets better than the male rats, 
which can be affected by their active hormonal changes or other differences in biological 
differences. 
During the initial training in the choice procedure, all female rats showed a greater 
preference for the immediate lever (Figure 8).  
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Figure 8. The relationship between a choice for the delay lever vs the immediate lever among the 
PBS and MTX groups. A) Choice procedure performed by the PBS-injected rat. B) Choice 
procedure performed by the MTX-induced rat. An empty circle represents the choice for the 
immediate lever, while the filled square represents the omission during the trial. Preference for 
an immediate lever was negatively correlated with an increased time of delays, while the number 
of trial omissions was positively correlated with the increased time of the delays in the PBS 
group, whereas the MTX group showed a less clear relationship. 
 
Interestingly, the number of immediate lever presses decreased as the delay time increased. This 
relationship was unexpected as the reward for the delay lever was fixed at five sucrose pellets 
regardless of the length of the delay period. However, this correlation can be explained by the 
number of omissions. As the trial went on, the choice for the sucrose pellet itself decreased as the 
omission increased with the increase in the delay time. This behavior needs further investigation. 
Although the correlation was clear in the PBS individual, the MTX-induced rat did not show as 
much difference in this relationship.  
 After they learned the delay-lever functions, the further choice procedure showed 
different responses between the control group and the MTX-induced group (Figure 9).  
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Figure 9. The preference for the delay lever and the number of omissions in relation to the time 
of delay. A) The control group (PBS-treated) showed the preference of the delay lever at the 
beginning of the session, while the MTX-treated group did not choose the delay lever throughout 
the session. B) Both groups still indicated a high percentage of omission especially towards the 
end of the experiment. 
 
The MTX group exclusively preferred the immediate reinforcer, while the control group chose 
the delay lever for the first quarter of the session. This decrease in delay-lever preference 
overtime was expected, as the delay period gets longer, while the delay-reward is fixed to five 
sucrose pellets. The overall omissions of the trials were still high, which may be related to their 
age. 
Discussion 
Administering MTX to the rats who are undergoing an active development of the brain 
structure had a significant impact on various areas of the cognitive functions. The extent of 
which MTX chemotherapy damages the neuronal development, as well as other hormonal 
regulations, is not well examined. This study, then, was able to demonstrate the phenotypic 
characteristics of the MTX-treated rats by observing behavioral changes. The task was validated 
as the prolonged trials still allowed the subjects to remain sensitive to the signals of the number 
of sucrose pellets. 
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The preliminary studies showed that both male and female rats will produce the results 
that will be more generalized among the population. The female rats consistently pressed for 
more sucrose pellets compared to the male rats, which resulted in a higher number of ingestions 
of sucrose pellets for the female rats than the male rats. An exclusion of the female rats as the 
animal models from the study, which has been the case for a long time in the past due to the fact 
that the females experience a menstrual cycle every four to five days can skew the 
generalizability of the results. 
NOR test was performed once a month (total three months) to observe any development 
or deterioration of working memory as well as cognitive functions. This experiment served as a 
positive control as the defects in brain development were expected from the rats who are 
disturbed by the MTX toxicity at an early age. Although the MTX-induced rats seemed to 
recognize the novel object, it was clear their response to the new subject was less noticeable 
compared to the non-affected group. This result is consistent with the clinical findings as the 
cancer-survivors in their young age with early exposure to MTX experience partially abnormal 
performance in their academic fields compared to healthy peers (Ikonomidou, 2018; van der Plas 
et al., 2015). This result supported the difference in cognitive functions between the PBS and the 
MTX groups prior to learning their difference in impulsiveness. 
In the discounting task, all rats recognized the consequences of pressing a certain lever 
(the left for 5 sucrose pellets and the right lever for 1 sucrose pellet) within the first two weeks of 
training. The completion of training confirmed that the adolescent rats were able to comprehend 
the signals and respond appropriately regarding their desirable choices. At the beginning of the 
choice test, all rats tend to prefer the immediate lever more than the delay lever. The correlation 
test was performed based on the percent preference of the immediate lever and the length of the 
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delay time of the delay lever. The female rat who was not exposed to MTX in her early stage (23 
days old) showed over 80% of preference for the immediate lever at the beginning of the session, 
expressing her desire to consume the sucrose pellets. This preference decreased as the session 
proceeded, while the omission of the trial increased simultaneously. This association can suggest 
that instead of choosing the delay lever, the rat may have recognized her satiety and decided to 
stop eating more sucrose pellets. In contrast to the PBS rat, the MTX rat showed little relation 
between the preference of the immediate lever and the time of delay throughout the discounting 
task session. No significant difference in choosing the lever in the experimental rat can 
demonstrate the overall withdrawn ability to perform tasks with the appropriate understanding of 
the levers. The comparable responses between the control group and the MTX-exposed group 
were observed, indicating that the altered executive functions to consume less number of sucrose 
pellets by choosing the immediate lever in the MTX rats show impulsive behavior, which can be 
associated with the MTX impact on daily tasks. 
The MTX-induced impulsive behavior became more evident in the experimental models 
throughout the choice procedures. The MTX-administered rats completely ignored the choice of 
having a higher reward (five sucrose pellets), but rather chose to receive one sucrose pellet. 
MTX’s impact on the rats suggested intolerance against the temptation of having food 
instantaneously. Although the MTX injection took place on day 24 after birth, the cognitive 
deficits were still evident on day 71 after birth. This finding suggested that the time it took for 
MTX to alter a behavioral aspect—in this case, impulsiveness—far exceeded the half-life of 
MTX. The novel discovery that MTX contributes to the development of the impulsiveness at a 
later time for the rat models was consistent with other studies where the aberrant cognitive 
functioning persistently decreased in the clinical patients who survived ALL. The experimental 
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design was to mimic the developing brain with an independent variable of injecting MTX 
without the presence of cancer. This condition exclusively targets the influence of MTX 
disregarding the possible negative effect by cancer itself, highlighting that prevalence of 
neurocognitive dysfunction among young patients who had undergone the chemotherapy is most 
likely induced by the drug. 
Considering the half-life of methotrexate, the rats’ metabolic activity will be able to 
eliminate MTX from the biological systems in approximately 90 minutes (Fahrig, Brasch, & 
Iven, 1989). There was only a one-time injection of MTX at the beginning of the experiment 
before the rats underwent the training and the experimental sessions. Then, the long-lasting 
effect of MTX may be via other intermediate components. Such interpretation is also implied by 
other studies, demonstrating that MTX not only halts the active cell divisions but also has an 
indirect effect on cellular apoptosis observed in patients with rheumatoid arthritis (Spurlock et 
al., 2011). In fact, reactive oxygen species are commonly found in the body exposed to MTX 
treatment. Those molecules cause oxidative stress in the cell and if the condition is not reversed, 
the affected cell shows an increase in sensitivity to apoptosis. Rheumatoid arthritis patients are 
usually administered a low dose of MTX, while the majority of MTX chemotherapy suggested 
treating for ALL and other cancers require a high dose MTX, which is known to affect the young 
female patients the most (Holmboe, Andersen, Morkrid, Slordal, & Hall, 2012). In terms of the 
MTX impact of brain cell deaths, the reliance on temporal precedence between MTX injection 
and the development of behavioral disorders explains that there are missing keys to instigate the 
abnormal responses in the brain. The intermediate molecules that mitigate the brain function in 
response to MTX impact should be investigated further (Angelov et al., 2009). 
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The behavioral analyses were performed by investigating the frequency of omission 
during the trials. The unexpected omissions after successful training of recognizing the lever 
functions suggest a few interpretations. Ignoring the signals from the PBS rats can be due to the 
loss in appetite, as they have acquired more sucrose pellets during the first few trials of the 
session, which provided them with over five times what they will normally ingest during their 
training session. On the other hand, the MTX-administered rats showed a consistent percentage 
of omissions, indicating that their behavior depends on random failure to press the lever due to 
lack of attention ability. Additionally, the decrease in physical activity could be assessed as if the 
rats were choosing not to press the lever or were challenged, moving from place to place, and 
pressing the levers. Since the omissions were prominent throughout the session in the MTX 
group compared to the control group, a possible interpretation of withdrawal in physical activity 
can point to the presence of the pain, although this factor was not specifically targeted in our 
study. The reduction in physical strength or alteration in an ability to pay attention due to the 
unbalanced biological homeostasis may be able to point at the sensation of pain. 
In short, the mechanism of action for MTX in the adolescent rat models demands longer 
than a month to undermine cognitive deficits, but the impulsive behavior was present within two 
months after the MTX injection. This timeline of one to two months in the rats is equivalent to 
two and a half years to five years in human years, supporting that five years after the MTX 
exposure will show phenotypic symptoms in cognitive behaviors in young children (Sengupta, 
2013). 
This study was limited due to the small sample size of the animal models, questioning the 
generalizability. However, using both male and female rats helped minimize biased results. 
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As the study on the adolescent rat models were never done in the past, the appropriate 
doses of MTX per body mass was not accurately determined and the doses that were used were 
proven to be fatal for some rat models. 
The adolescent rats not only have developing brains, but also growing bodies, indicating 
that accounting for the possible hormonal influences playing the role in these rats can be 
confounding factors. 
Conclusion 
The chemotherapy, MTX, despite its effect on curing various cancers including ALL, implies 
some detrimental disorders in cancer survivors. In this study, the degree of the negative effect of 
MTX on the actively developing brain was closely investigated. The experiment was conducted, 
according to the baseline obtained for the male and female rats’ tendency to consume sucrose 
pellets. Administration of MTX to the animal models accompanied a decrease in working 
memory evidenced by the NOR test, which served as a positive control. MTX’s impact on 
impulsive behavior was evident from the discounting task. From the choice procedure, the MTX 
rats exclusively chose the immediate lever to receive one sucrose pellet and discounted the 
values of the rewards after delays. Additionally, the degree of discomfort could have been a 
factor based on the frequency of omission. MTX group’s random omissions could point to a 
decrease in attention skills or physical discomfort. The collaborative results indicate that MTX 
requires longer than a month to show the distinctive cognitive deficits in the adolescent rats, but 
the drug accompanies impulsive behavior within two months of being exposed to chemotherapy, 
comparable to the drug’s effect on young children. 
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